Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kroopa Joshi

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Opinion in Immunology|August 28, 2021
Application of T cell receptor (TCR) repertoire analysis for the advancement of cancer immunotherapyKroopa Joshi, Martina Milighetti, Benjamin M Chain
Cancer Cell|April 12, 2022
Tracking down tumor-specific T cellsJames Reading, Kane Foster, Kroopa Joshi, et al.
Cancer Treatment Reviews|September 18, 2021
Systemic therapy for older patients with early breast cancerNicolò Matteo Luca Battisti, Kroopa Joshi, Mariam Syeda Nasser, et al.
Cold Spring Harbor Perspectives in Medicine|June 21, 2017
The "Achilles' Heel" of Cancer and Its Implications for the Development of Novel Immunotherapeutic StrategiesKroopa Joshi, Benjamin M Chain, Karl S Peggs, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2018
An Economical, Quantitative, and Robust Protocol for High-Throughput T Cell Receptor Sequencing from Tumor or BloodImran Uddin, Kroopa Joshi, Theres Oakes, et al.
Therapeutic Advances in Medical Oncology|June 17, 2026
Cytokine release syndrome in solid tumours: mechanism-based therapeutic strategies for prevention and managementFederico Monaca, Rachel Woodford, Kroopa Joshi, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2015
Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case reportJuan Martin-Liberal, Andrew Js Furness, Kroopa Joshi, et al.
Methods in Enzymology|November 16, 2019
Quantitative analysis of the T cell receptor repertoireImran Uddin, Annemarie Woolston, Thomas Peacock, et al.
The Lancet. Oncology|June 9, 2017
Evolving adoptive cellular therapies in urological malignanciesYien Ning Sophia Wong, Kroopa Joshi, Martin Pule, et al.
Lung Cancer (Amsterdam, Netherlands)|May 9, 2021
Safety monitoring of two and four-weekly adjuvant durvalumab for patients with stage III NSCLC: implications for the COVID-19 pandemic and beyondKroopa Joshi, Abdul Muhith, Mariam Obeid, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Opinion in Immunology|August 28, 2021
Application of T cell receptor (TCR) repertoire analysis for the advancement of cancer immunotherapyKroopa Joshi, Martina Milighetti, Benjamin M Chain
Cancer Cell|April 12, 2022
Tracking down tumor-specific T cellsJames Reading, Kane Foster, Kroopa Joshi, et al.
Cancer Treatment Reviews|September 18, 2021
Systemic therapy for older patients with early breast cancerNicolò Matteo Luca Battisti, Kroopa Joshi, Mariam Syeda Nasser, et al.
Cold Spring Harbor Perspectives in Medicine|June 21, 2017
The "Achilles' Heel" of Cancer and Its Implications for the Development of Novel Immunotherapeutic StrategiesKroopa Joshi, Benjamin M Chain, Karl S Peggs, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2018
An Economical, Quantitative, and Robust Protocol for High-Throughput T Cell Receptor Sequencing from Tumor or BloodImran Uddin, Kroopa Joshi, Theres Oakes, et al.
Therapeutic Advances in Medical Oncology|June 17, 2026
Cytokine release syndrome in solid tumours: mechanism-based therapeutic strategies for prevention and managementFederico Monaca, Rachel Woodford, Kroopa Joshi, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2015
Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case reportJuan Martin-Liberal, Andrew Js Furness, Kroopa Joshi, et al.
Methods in Enzymology|November 16, 2019
Quantitative analysis of the T cell receptor repertoireImran Uddin, Annemarie Woolston, Thomas Peacock, et al.
The Lancet. Oncology|June 9, 2017
Evolving adoptive cellular therapies in urological malignanciesYien Ning Sophia Wong, Kroopa Joshi, Martin Pule, et al.
Lung Cancer (Amsterdam, Netherlands)|May 9, 2021
Safety monitoring of two and four-weekly adjuvant durvalumab for patients with stage III NSCLC: implications for the COVID-19 pandemic and beyondKroopa Joshi, Abdul Muhith, Mariam Obeid, et al.
Pageof 3